Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Shattuck Labs (STTK) Cash & Equivalents (2019 - 2025)

Shattuck Labs (STTK) has disclosed Cash & Equivalents for 7 consecutive years, with $54.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 5.57% to $54.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.2 million through Dec 2025, down 5.57% year-over-year, with the annual reading at $54.2 million for FY2025, 5.57% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $54.2 million at Shattuck Labs, up from $42.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $125.6 million in Q4 2023, with the low at $37.9 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $63.7 million, with a median of $59.0 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents tumbled 56.22% in 2022, then soared 165.15% in 2023.
  • Over 5 years, Cash & Equivalents stood at $92.3 million in 2021, then plummeted by 48.65% to $47.4 million in 2022, then skyrocketed by 165.15% to $125.6 million in 2023, then tumbled by 54.32% to $57.4 million in 2024, then dropped by 5.57% to $54.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $54.2 million, $42.5 million, and $50.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.